Acronym: PREDICT2 |
Main Objective: Development of an ELISA assay that will quantitatively measure the response to endocrine therapy in breast cancer. |
Reference: - |
Funding: P2020 |
Start Date: 01-09-2020 |
End Date: 31-01-2021 |
Team: Nélia Jordão Alberto, Maria de Fátima Fonseca Domingues, Ayman Mohamed M. Radwan, Luisa Helguero, Samuel Guieu, Inês Direito, Fátima Monteiro, Ana Joaquim |
Groups: Optical Sensors and Integrated Photonics - Av, Mobile Networks – Av |
Partners: CICECO, iBiMED, LAQV/REQUIMTE |
Local Coordinator: Nélia Jordão Alberto |
|
Associated Publications
|